Expert Consensus on Tumor Mutational Burden for Immunotherapy in Lung Cancer
Lung cancer is one of the malignant tumors with the highest morbidity and mortality in the world. Immune checkpoint inhibitors (ICIs), including programmed cell death 1 (PD-1) antibody, programmed cell death ligand 1 (PD-L1) antibody, and cytotoxic T lymphocyte associated protein 4 (CTLA-4) antibody...
Enregistré dans:
| Auteurs principaux: | , |
|---|---|
| Format: | article |
| Langue: | ZH |
| Publié: |
Chinese Anti-Cancer Association; Chinese Antituberculosis Association
2021
|
| Sujets: | |
| Accès en ligne: | https://doaj.org/article/73efbbca7aad481c9495e49e699bda8c |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|